Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease Jeffrey CummingsAmanda M. Leisgang OsseJingchun Chen Review Article Open access 13 November 2023 Pages: 5 - 22
Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access Beate BittnerJohannes Schmidt Review Article Open access 13 October 2023 Pages: 23 - 46
Outer Membrane Vesicle Vaccine Platforms Francesca MicoliRoberto AdamoUsman Nakakana Review Article Open access 05 October 2023 Pages: 47 - 59
Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned? Ali Berkant AvciEugen FeistGerd R. Burmester Review Article Open access 21 November 2023 Pages: 61 - 71
AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies Brenda F. M. CastroJason C. SteelChristopher J. Layton Review Article Open access 25 October 2023 Pages: 73 - 93
Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review Sylwia SzwecZuzanna KapłuchaPatryk Konieczny Review Article Open access 02 November 2023 Pages: 95 - 119
Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study Kim A. PappMark G. LebwohlWoori Ko Original Research Article Open access 22 November 2023 Pages: 121 - 131
Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries Hyunjung WooGyeongseon ShinSeungJin Bae Original Research Article Open access 08 December 2023 Pages: 133 - 144
Ixekizumab for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 52-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study Yu XueJiankang HuHejian Zou Original Research Article 22 September 2023 Pages: 145 - 156
Immunotherapy Guided by Immunohistochemistry PD-L1 Testing for Patients with NSCLC: A Microsimulation Model-Based Effectiveness and Cost-Effectiveness Analysis Mingjun RuiYingcheng WangZhengyang Fei Original Research Article 04 October 2023 Pages: 157 - 170